Therapeutic alternatives for sporotrichosis induced by wild-type and non-wild-type Sporothrix schenckii through in vitro and in vivo assessment of enilconazole, isavuconazole, posaconazole, and terbinafine
Abstract This study explores the effectiveness of various antifungal drugs in treating sporotrichosis caused by Sporothrix schenckii, especially in non-wild-type (non-WT) strains. The drugs tested include enilconazole (ENIL), isavuconazole (ISA), posaconazole (POS), terbinafine (TER), and itraconazo...
Saved in:
Main Authors: | Vasurom Aroonvuthiphong, Norasuthi Bangphoomi |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-01-01
|
Series: | Scientific Reports |
Subjects: | |
Online Access: | https://doi.org/10.1038/s41598-025-87711-3 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Atypical conjunctival sporotrichosis secondary to Mooren’s ulcer: a case report
by: Qing Su, et al.
Published: (2025-01-01) -
Microbiological Isolation of Sporothrix Schenckii in an Immunocompromised Patient. A Case Report
by: Ledys Pérez Morales, et al.
Published: (2014-08-01) -
Sporotrichosis in the earlobe caused by placing an earing
by: Evelyn Zacarias, et al.
Published: (2025-01-01) -
Isolated Sporothrix schenckii Monoarthritis
by: Aram Barbaryan, et al.
Published: (2018-01-01) -
Application of Principal Component Analysis as a Prediction Model for Feline Sporotrichosis
by: Franco Bresolin Pegoraro, et al.
Published: (2025-01-01)